AstraZeneca CEO Pascal Sorio, a veterinarian, is expected to become the next CEO of Teva Pharmaceuticals, according to an article in Calcalist, a financial website. Sorio, who was AZ's CEO for almost five years, made headlines in 2016 when shareholders protested his $17.3 million annual salary.
Sorio reportedly agreed to accept the position with a signing bonus of $15M to $20M, and an annual salary almost double what the predecessor CEO, Erez Vigodman, received--upward of $11 million.
Read the full story (translation may be required)